Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Australian researchers from Southern Cross University (SCU) and the Melbourne Integrative Oncology Group (MIOG) will launch a clinical study investigating whether hyperbaric oxygen therapy (HBOT) can ...

New research from a University of Cincinnati Cancer Center study found external beam radiation therapy (EBRT) is safe to ...

The FinCan study, conducted by oncologists and health economists, provided fresh insights into the programme's strengths and ...

BAGUIO CITY — The Philippine Oncology Center Corp. (POCC) thanked the city government of Baguio for the consummation of an agreement that seeks to provide free cancer treatment services to qualified ...

Prostate cancer is the leading cancer among Kenyan men, with an estimated 3,582 men being diagnosed with the disease at some ...

AstraZeneca PLC (NYSE:AZN) is one of Goldman Sachs top healthcare stocks. On March 9, AstraZeneca PLC (NYSE:AZN) and Daiichi ...

Study to test RC220 alongside standard-of-care osimertinib to prevent or delay treatment resistance. ... Read More The post Racura secures green light for RC220 HARNESS-1 lung cancer trial appeared ...

Eight-year-old dog Rosie, once abandoned in bushland, found a new lease on life when ...

HBC Construction Limited (HBC), formerly Henry Boot Construction, has begun work on a new cancer centre in Leeds.

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...